MEMORIAL SLOAN KETTERING CANCER CENTER and Cornell University are opening a new $10 million Center of Cancer Nanotechnology Excellence. The MSKCC-Cornell Center for Translation of Cancer Nanomedicines is funded with an $8.2 million grant from the NCI Alliance for Nanotechnology in Cancer and more than $1.9 million from MSKCC. The center—which will have one facility... […]
NYU LANGONE MEDICAL CENTER established a program in biologics research, appointing Shohei Koide to lead the new initiative. Koide will join NYU Langone March 1, 2016 as director of cancer biologics at the Laura and Isaac Perlmutter Cancer Center. “No other academic medical institution on the East Coast has a major presence in biologics research,”... […]
VICTORIA SEEWALDT was named the Ruth Ziegler Chair in Population Sciences at City of Hope. Seewaldt will also serve as the associate director of the comprehensive cancer center. Previously, she was a professor of medicine at Duke University and leader of the Comprehensive Cancer Breast and Ovarian Cancer Program. She also founded the institution’s community... […]
ALEXANDER EGGERMONT, general director of Institut Gustave Roussy since 2010, has had his appointment as head of the institute renewed by the French minister of health for another five years. The institute is one of the largest health centers in Europe dedicated to oncology. The past five years has seen a large investment program at... […]
RICHARD O'REILLY will step down as chair of pediatrics at Memorial Sloan Kettering Cancer Center, after nearly 30 years. He will serve as chair until a successor is found, according to Physician-in-Chief Jose Baselga.
THE CENTER TO ADVANCE PALLIATIVE CARE and National Palliative Care Research Center published a state-by-state report card evaluating access to palliative care.
A STAND UP TO CANCER CANADA DREAM TEAM researching approaches to treating triple-negative breast cancer and other aggressive types of breast cancer has been formed following a $9 million investment from a coalition of funders.
JAN SCHLÜCHTER was named chief commercial officer of Myriad Genetics GmbH, effective Oct. 15.
KIRAN TURAGA was named the Sharon K. Wadina Endowed Professor in Sarcoma Research at the Medical College of Wisconsin.
JAMES WADE was named deputy director for quality and network development at the Inova Dwight and Martha Schar Cancer Institute.
